Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000878989 | SCV001021996 | likely benign | Acyl-CoA oxidase deficiency | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV004792568 | SCV005412844 | uncertain significance | not provided | 2023-12-29 | criteria provided, single submitter | clinical testing | BS1, PP3 |
Natera, |
RCV000878989 | SCV001463458 | uncertain significance | Acyl-CoA oxidase deficiency | 2019-11-11 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004738045 | SCV005346181 | likely benign | ACOX1-related disorder | 2024-04-11 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |